Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Gnomestar Craft Inc VDQSF

Gnomestar Craft Inc. is a Canada-based craft cannabis company. The Company is engaged in the medical and recreational marijuana business. It operates in one business segment, the marijuana industry. The Company produces hand trimmed cultivars in its 12,000 square foot indoor facility in Delta, British Columbia.


GREY:VDQSF - Post by User

Bullboard Posts
Post by Analyzerrrron Sep 21, 2017 8:36am
112 Views
Post# 26724391

Here u go. Was waiting for this update from Aug.

Here u go. Was waiting for this update from Aug.

Vodis Pharmaceuticals : Investor Update

Envoyer par e-mail
 
09/21/2017 | 01:54 pm

September 21, 2017, Vancouver, British Columbia - Vodis Pharmaceuticals Inc.(CSE: VP / FSE: 1JV1) ('Vodis' or the 'Company') is pleased to inform investors that it is among the set of applicants to have recently been contacted by Health Canada. The Company's application to produce cannabis under the 'Access to Cannabis for Medical Purposes Regulations' (ACMPR) in Canada is currently in 'Active Review'. The Company is in the process of upgrading its Delta facility to meet the requirements of the ACMPR, which have changed since the Company's original application under the 'Marihuana for Medical Purposes Regulations' (MMPR). These updates include minor hardware upgrades to its video surveillance and intrusion detection systems and installation of a seed-to-sale tracking system. Vodis plans to select Canadian-made Ample Organics as its seed-to-sale tracking system provider.

Vodis is also pleased to announce that the expansion to its facility in Bellingham, WA, announced March 23, 2017, is approximately 75% complete. This work involved major structural changes to the building to support the construction of a 2 floor within the facility above previously licensed, unused, canopy space. At present the completed work will allow the Company's tenant, Premium Cannabis Producers LLC ('PCP'), to double its current production capacity. Upon completion, the facility will support the full 10,000 sq ft of PCP's Tier 2 license capacity. The Company anticipates the Bellingham expansion to be complete before the end of the year.

This news release shall not constitute an offer to sell or solicitation of an offer to buy the securities in any jurisdiction. The securities will not be and have not been registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or applicable exemption from the registration requirements.

 

Bullboard Posts